Depression: open trials in Bulgaria

7 open trials have a site in Bulgaria. Registry data; only the trial team decides who can take part.

NCT06559306
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Center For Mental Health Prof. Dr. Ivan Temkov Burgas EOOD, Burgas · University Multiprofile Hospital For Active Treatment Saint Georgi EAD, Plovdiv · Center For Mental Health Prof. N. Shipkovenski EOOD, Sofia · Medical Center Saint Naum EOOD, Sofiya · Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD, Sofiya · Medical Center Zara-Med EOOD, Stara Zagora · Diagnostics-Consultancy Center Mladost M Varna OOD, Varna
Registry updated 2026-11-03
NCT06966401
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Trial Treatment · Phase 3 · Neurocrine Biosciences
Medical Center Lifemed EOOD, Kirdzhali · Medical Center Mentalcare Ltd., Plovdiv · Center For Mental Health Ruse EOOD, Ruse · Medical Center Intermedica Ltd., Sofia · Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD, Sofiya · Medical Center Hera EOOD, Sofiya · Medical Center Saint Naum EOOD, Sofiya · Diagnostics-Consultancy Center Mladost M Varna OOD, Varna
Registry updated 2026-11-02
NCT07300969
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Trial Treatment · Phase 2 · Draig Therapeutics Ltd
Draig Clinical Site, Kazanlak · Draig Clinical Site, Plovdiv · Draig Clinical Site, Sofia · Draig Clinical Site, Vratsa
Registry updated 2026-10-08
NCT07065240
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Trial Treatment · Phase 2 · Seaport Therapeutics
State Psychiatric Hospital - Lovech, Lovech · Medical Center Mentalcare Ltd., Plovdiv · Medical Center Intermedica Ltd., Sofia · Mental Health Center Sofia EOOD, Sofia
Registry updated 2026-10-06
NCT07161700
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
Trial Treatment · Phase 2 · Seaport Therapeutics
State Psychiatric Hospital - Lovech, Lovech · Medical Center Mentalcare Ltd., Plovdiv · Mental Health Center Sofia EOOD, Sofia · Medical Center Intermedica Ltd., Sofia
Registry updated 2026-10-06
2025-522784-15-00
DT-101 in Adults with Major Depressive Disorder
Trial Treatment · Phase 2 · Draig Therapeutics Limited
Dr. Ivo Natsov Outpatient Clinic For Individual Practice For Specialized Medical Care In Psychiatry ET, Cherven Bryag · Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD, Kazanlik · University Multiprofile Hospital For Active Treatment Saint Georgi EAD, Plovdiv · Mental Health Center Sofia EOOD, Sofia · Multiprofile Hospital For Active Treatment In Neurology And Psychiatry St. Naum EAD, Sofia · Medical Center Hera EOOD, Sofiya · Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD, Sofiya · Center For Mental Health Vratsa EOOD, Vratsa
Registry updated 2026-08-17
NCT06911112
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Trial Treatment · Phase 3 · Neurocrine Biosciences
Medical Center Lifemed EOOD, Kirdzhali · Medical Center Mentalcare Ltd., Plovdiv · Center For Mental Health Ruse EOOD, Ruse · Medical Center Hera EOOD, Sofiya · Medical Center Saint Naum EOOD, Sofiya · Diagnostics-Consultancy Center Mladost M Varna OOD, Varna
Registry updated 2026-08-11

All Depression trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Depression: open trials in Bulgaria

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

DT-101 in Adults with Major Depressive Disorder

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)